Vext Science Earnings Call Highlights Ohio-Led Turnaround

Vext Science ((TSE:VEXT)) has held its Q1 earnings call. Read on for the main highlights of the call.

Vext Science’s latest earnings call struck a cautiously upbeat tone, highlighting tangible progress on revenue growth, margins, and cash generation while confronting real pressures in Arizona and rising competitive risks in Ohio. Management framed 2026 as a year of disciplined execution, emphasizing that strategic shifts already underway are starting to reshape the company’s financial profile.

Consolidated Revenue Growth

Vext reported Q1 2026 revenue of $12.2 million, up about 5.2% year over year, as robust Ohio performance outweighed weakness in Arizona. Management stressed that the portfolio is increasingly oriented toward higher-return markets, with Ohio’s retail engine now firmly driving consolidated top-line growth.

Material Gross Profit and Margin Expansion

Gross profit more than doubled to $5.5 million, lifting the reported gross margin to 45.4% from 19.7% a year earlier. Even before fair value adjustments, gross profit improved to $4.4 million with a 35.8% margin, underscoring early success in cost discipline and mix shift toward higher-margin retail.

Adjusted EBITDA and Profitability Progress

Adjusted EBITDA reached $3.6 million with a 29.3% margin in Q1, up sharply from $2.1 million and a 15% margin in Q4 2025. The company essentially matched its prior-year Q1 EBITDA performance despite market headwinds, signaling improved operating leverage and tighter expense control.

Net Loss Narrows Sharply

Net loss narrowed to $0.9 million in Q1 2026 from $3.3 million a year earlier, an improvement of roughly 73%. Management framed this as evidence that the business is moving closer to true profitability, with further benefit expected as Arizona restructuring flows through results.

Positive Operating Cash Flow

Vext generated $1.6 million in cash from operations in Q1, a 13% cash flow margin that lifted the cash balance to approximately $5.5 million from $5.1 million at year-end 2025. Management noted this was achieved despite transition-related headwinds, reinforcing confidence in the company’s ability to self-fund much of its strategy.

Ohio: Core Growth Engine

Ohio revenue surged 34% year over year to $8.2 million, outpacing statewide sales growth of over 20% in early 2026 and confirming Vext’s share gains. The company plans to open its sixth dispensary in Fairfield in Q2, a seventh in Columbus later in 2026, and an eighth in early 2027, with drive-thru capabilities a key differentiator.

Cultivation Yields and Sourcing Advantage

Ohio cultivation yields improved nearly 15% in Q1, with management expecting further gains in Q2 as operations scale and efficiencies kick in. At the same time, Vext aims to source wholesale product at about $400–$500 per pound, sometimes below $400, a sharp discount to the roughly $800–$900 per pound cost of its former Arizona cultivation.

Strategic Exit from Arizona Cultivation

The company is executing a decisive exit from its Eloy cultivation facility, with final harvest completed in early May and full shutdown targeted by the end of Q2. Going forward, Arizona will focus on two Phoenix Metro dispensaries and light manufacturing, a shift expected to cut operating costs and improve overall margins and cash flow.

Arizona Revenue Pressure and Wholesale Compression

Arizona revenue fell 24% year over year as the market remains oversupplied and wholesale pricing stays under pressure. Consolidated wholesale revenue dropped about 50% to $1.7 million, reflecting both the pricing environment and Vext’s deliberate pivot to a retail-first strategy amid temporary supply tightness.

Temporary Cash Drag from Transition

Operating cash flow was partially weighed down by lingering drag from Arizona cultivation in its final quarter and timing-related working capital swings. Management expects these headwinds to reverse in Q2 and Q3 as the Eloy exit is completed and balance-sheet items normalize.

Tax Liability Uncertainty

Vext’s uncertain tax position climbed to $10.6 million at March 31, 2026, from $8.1 million at year-end, driven by adjustments between its 2025 tax provision and actual returns. While possible regulatory changes could meaningfully reduce this burden, management is not yet recognizing any benefit, leaving a significant tax overhang on the balance sheet.

Rising Competition in Ohio

Management acknowledged that Ohio is beginning to mature, with more dispensaries opening, particularly in Columbus, and gradual pricing pressure in select categories. This intensifying competition raises execution risk, making scale, customer experience, and cost efficiency critical to sustaining margins as the store base expands.

Capex and Permitting Risks

The build-out of remaining Ohio stores comes with meaningful capital needs, including roughly $3.0–$3.2 million for the Columbus location and about $2.0–$2.5 million for the eighth site. Permitting and construction delays, which have already pushed the eighth store into early 2027, could impact the pace and timing of future cash returns.

Guidance and Outlook

For 2026, Vext is guiding to continued execution around scaling Ohio retail and completing the Arizona cultivation exit, with full cash benefits expected from Q3 onward. Management anticipates improving operating leverage, further margin expansion, better yields, and ongoing cash generation as new Ohio stores ramp over one to four months and sourcing costs fall.

Vext’s earnings call painted a picture of a company leaning into its strengths while making tough choices to address weak spots. Investors will be watching whether Ohio’s growth and margin gains can offset Arizona’s drag and tax uncertainty, but for now the story is one of disciplined transition toward a more focused, higher-return platform.